Sana Biotechnology (SANA) Other Operating Expenses (2020 - 2026)

Sana Biotechnology has reported Other Operating Expenses for 7 years, with the latest figure at $8.4 million in Q1 2026.

• Quarterly Other Operating Expenses rose 330.91% year-over-year to $8.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$112.1 million (up 25.72% YoY) and the FY2025 annual result came in at -$167.0 million, up 36.94% from the prior year.
• Other Operating Expenses improved to $8.4 million in Q1 2026 per SANA's latest filing, from -$44.3 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $26.7 million in Q2 2023 and troughed at -$249.4 million in Q4 2022.
• A 5-year average of -$54.5 million and a median of -$38.3 million in 2025 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2024 and 2026: Other Operating Expenses sank 57315.0% in 2024, then surged 330.91% in 2026.
• Over 5 years, Other Operating Expenses stood at -$249.4 million in 2022, then advanced by 15.82% to -$210.0 million in 2023, then soared by 92.11% to -$16.6 million in 2024, then sank by 167.52% to -$44.3 million in 2025, then jumped by 119.02% to $8.4 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $8.4 million, -$44.3 million, and -$38.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.